Endocrine News has compiled the leading breakthroughs in endocrine research over the course of the past year with the help from 11 editors from Endocrine Reviews. From genetic research to new thyroid cancer drugs, amazing progress is being made in the field of endocrinology. Each year brings us a little closer to solving complex endocrine...
Long-term outcome data supporting the use of a test used to identify patients whose thyroid nodules are noncancerous when their fine needle aspiration (FNA) biopsy results are inconclusive were recently published in The Journal of Clinical Endocrinology & Metabolism. The test is marketed by Veracyte as the Afirma Gene Expression Classifier (GEC). Researchers led by Trevor E. Angell, MD,...
Misrepresentations surround the occurrence, causes, and
treatment of thyroid cancer in the pediatric patient population.
It’s not as “rare” as once thought, and despite its treatability,
there is still a ways to go in separating fact from fiction.
Advances in genetic testing have been crucial to discovering the underlying causes of many endocrine disorders. They not only act as a guide to treatment but also as a precaution for family members.
A new study reveals that hypoparathyroid patients experience more distress from this disorder than previously realized. Could a new treatment option finally be within reach?
In the last 40 years thyroid cancer rates have tripled, yet mortality has stayed the same. Has there been an unusually aggressive rush to judgment in diagnosing thyroid cancer?
One of the most confounding endocrine emergencies in
history, thyroid storm is no longer a death sentence. Here’s
a look at what’s new on the horizon in the prevention,
recognition, and treatment of this once fatal malady.
Endocrine News provides the latest news and research articles on thyroid conditions and treatment. For more info read this month’s issue of Endocrine News.